Notably, CDK4/6is exert anti-tumor immune effects by enhancing tumor antigen presentation, mediating the senescence phenotype that activates the immune system, inducing immunogenic cell death, enhancing T cell infiltration and activation, and reducing immunosuppressive cells. Here, CDK4 is linked to neoplasm.